Gem Corpochem Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 3.01 Cr
as on 17-07-2024
- Company Age 11 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 25.50 Cr
as on 17-07-2024
- Satisfied Charges ₹ 6.44 Cr
as on 17-07-2024
- Revenue 48.52%
(FY 2023)
- Profit 105.47%
(FY 2023)
- Ebitda 94.50%
(FY 2023)
- Net Worth 35.76%
(FY 2023)
- Total Assets 12.08%
(FY 2023)
About Gem Corpochem
The Company is engaged in the Chemicals And Resources Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.01 Cr.
The company currently has active open charges totaling ₹25.50 Cr. The company has closed loans amounting to ₹6.44 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kinjal Mehta, Bharti Shah, and Bharat Shah serve as directors at the Company.
- CIN/LLPIN
U24297MH2013PTC239402
- Company No.
239402
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jan 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Gem Corpochem Private Limited offer?
Gem Corpochem Private Limited offers a wide range of products and services, including Juices, Soups & Soft Drinks, Fruit Juice, Oil Mill & Oil Extraction Machinery, Oil Production Plant.
Who are the key members and board of directors at Gem Corpochem?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bharat Shah  | Director | 12-Jan-2013 | Current |
| Kinjal Mehta | Director | 07-Jan-2013 | Current |
| Bharti Shah | Director | 12-Jan-2013 | Current |
Financial Performance and Corporate Structure Insights of Gem Corpochem.
Gem Corpochem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 48.52% increase. The company also saw a substantial improvement in profitability, with a 105.47% increase in profit. The company's net worth Soared by an impressive increase of 35.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gem Corpochem?
In 2023, Gem Corpochem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
5 months 20 days Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 28 May 2020 | ₹15.00 Cr | Open |
Others Creation Date: 09 Jan 2014 | ₹10.50 Cr | Open |
Others Creation Date: 03 Mar 2022 | ₹1.48 Cr | Satisfied |
How Many Employees Work at Gem Corpochem?
Gem Corpochem has a workforce of 49 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Mar 30, 2014, Gem Corpochem has raised a total of ₹ 3 Cr, with the most recent deal valued at ₹ 3 Cr. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
